Efficacy News and Research

RSS
Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

International reference standards for use of bone turnover markers in clinical studies recommended

International reference standards for use of bone turnover markers in clinical studies recommended

Proellex vaginal delivery exhibits four times activity of oral dose in animal study

Proellex vaginal delivery exhibits four times activity of oral dose in animal study

Cephalon receives second FDA Complete Response Letter for NUVIGIL sNDA

Cephalon receives second FDA Complete Response Letter for NUVIGIL sNDA

Biglycan protein offers potential therapy for muscular dystrophy

Biglycan protein offers potential therapy for muscular dystrophy

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Teva receives FDA complete response letter for glatiramer acetate 0.5mL injection sNDA

Teva receives FDA complete response letter for glatiramer acetate 0.5mL injection sNDA

Alimera receives FDA CRL for ILUVIEN NDA

Alimera receives FDA CRL for ILUVIEN NDA

MigreLief releases safe, proven effective supplement for children with migraines

MigreLief releases safe, proven effective supplement for children with migraines

Today's opinions: Ariz. hospital and abortion; Wall Street Journal's issues with PolitiFact; Calif.'s anti-smoking success

Today's opinions: Ariz. hospital and abortion; Wall Street Journal's issues with PolitiFact; Calif.'s anti-smoking success

Promising initial data from STABLE clinical trial for endovascular treatment of Type B aortic dissection

Promising initial data from STABLE clinical trial for endovascular treatment of Type B aortic dissection

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Gilead stops ARTEMIS-IPF ambrisentan Phase III clinical trial in idiopathic pulmonary fibrosis

Gilead stops ARTEMIS-IPF ambrisentan Phase III clinical trial in idiopathic pulmonary fibrosis

FDA approves Watson's novel oral contraceptive

FDA approves Watson's novel oral contraceptive

Tekmira begins patient dosing in TKM-PLK1 phase 1 trail for cancer

Tekmira begins patient dosing in TKM-PLK1 phase 1 trail for cancer

Researchers perform cord blood cell transplantation to treat child with ischemic brain injury

Researchers perform cord blood cell transplantation to treat child with ischemic brain injury

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Millennia compiles data on 100 wounds treated with Cytomedix AutoloGel System

Millennia compiles data on 100 wounds treated with Cytomedix AutoloGel System

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.